Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 75.35
+2.65 (3.65%)
Sep 29, 2025, 2:46 PM HKT
HKG:6855 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Net Income | -1,159 | -405.43 | -925.64 | -882.92 | -782.42 | -677.61 | Upgrade |
Depreciation & Amortization | 87.55 | 91.07 | 90.81 | 60.92 | 27.53 | 26.49 | Upgrade |
Other Amortization | 2.1 | 2.1 | 2.39 | 2 | 0.8 | 0.93 | Upgrade |
Loss (Gain) From Sale of Assets | -0.04 | -0.04 | -0 | -2.27 | 0.03 | 0 | Upgrade |
Loss (Gain) From Sale of Investments | 0.83 | 0.83 | 0.7 | 9.77 | 20.89 | 3.75 | Upgrade |
Loss (Gain) on Equity Investments | 0.28 | 0.28 | -1.08 | 0.28 | - | - | Upgrade |
Stock-Based Compensation | 20.92 | 20.92 | 31.5 | 22.11 | 46.97 | 74.03 | Upgrade |
Other Operating Activities | 747.5 | 67.94 | 84.39 | 31.81 | -108.13 | 10.19 | Upgrade |
Change in Accounts Receivable | 62.75 | 62.75 | -91.54 | -0.39 | -53.97 | - | Upgrade |
Change in Inventory | 9.57 | 9.57 | -6.72 | -5.52 | -3.93 | - | Upgrade |
Change in Accounts Payable | 19.52 | 19.52 | -23.11 | 24.7 | 47.5 | 10.28 | Upgrade |
Change in Unearned Revenue | 4.09 | 4.09 | 82.98 | -24.66 | 227.39 | 5.11 | Upgrade |
Change in Other Net Operating Assets | 15.04 | 15.04 | 29.24 | 110.28 | -17.01 | -55.25 | Upgrade |
Operating Cash Flow | -189.09 | -111.36 | -726.08 | -653.92 | -604.68 | -609.96 | Upgrade |
Capital Expenditures | -27.8 | -24.29 | -46.11 | -203.29 | -435.42 | -249.92 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 0.01 | 2.35 | 0.34 | - | Upgrade |
Cash Acquisitions | -52.86 | -9.52 | -20 | -20 | -20 | - | Upgrade |
Sale (Purchase) of Intangibles | - | - | -10.74 | -33.68 | -1.21 | -1.56 | Upgrade |
Investment in Securities | -854.62 | -328.23 | 98.75 | -130 | -10.23 | 144.11 | Upgrade |
Investing Cash Flow | -935.28 | -362.04 | 21.92 | -384.61 | -466.52 | -107.37 | Upgrade |
Long-Term Debt Issued | - | 535.92 | 953.5 | 763.62 | 599.74 | 527.81 | Upgrade |
Long-Term Debt Repaid | - | -681.26 | -966.86 | -67.74 | -60.24 | -102.67 | Upgrade |
Net Debt Issued (Repaid) | -0.13 | -145.34 | -13.36 | 695.87 | 539.5 | 425.14 | Upgrade |
Issuance of Common Stock | 950.2 | 533.95 | 470.09 | 0.02 | 1,197 | 634.22 | Upgrade |
Repurchase of Common Stock | -7.24 | - | -5.92 | -26.78 | -25.87 | - | Upgrade |
Other Financing Activities | -74.22 | -73.84 | -82.06 | -49.85 | 70.97 | -19.35 | Upgrade |
Financing Cash Flow | 868.61 | 314.77 | 368.75 | 619.27 | 1,781 | 1,040 | Upgrade |
Foreign Exchange Rate Adjustments | 6.92 | 13.68 | 27.81 | 58.01 | -23.28 | -41.69 | Upgrade |
Net Cash Flow | -248.84 | -144.95 | -307.59 | -361.25 | 686.91 | 280.99 | Upgrade |
Free Cash Flow | -216.89 | -135.65 | -772.19 | -857.2 | -1,040 | -859.88 | Upgrade |
Free Cash Flow Margin | -55.53% | -13.83% | -347.86% | -408.75% | -3726.60% | -6906.64% | Upgrade |
Free Cash Flow Per Share | -0.66 | -0.45 | -2.73 | -3.25 | -4.08 | -3.98 | Upgrade |
Cash Interest Paid | 53.58 | 60.56 | 92.35 | 49.85 | 16.81 | 5.94 | Upgrade |
Cash Income Tax Paid | - | - | - | - | 3.85 | - | Upgrade |
Levered Free Cash Flow | 36.22 | -81.25 | -706.12 | -680.98 | -954.65 | -493.55 | Upgrade |
Unlevered Free Cash Flow | 72.58 | -40.96 | -646.09 | -647.99 | -944.19 | -489.65 | Upgrade |
Change in Working Capital | 110.97 | 110.97 | -9.15 | 104.41 | 189.65 | -47.73 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.